Lexeo Therapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & Equivalents | $63.0M | $35.0M | $121.5M | $77.3M |
| Accounts Receivable | — | — | — | — |
| Inventory | — | — | — | — |
| Total Current Assets | $188.4M | $126.1M | $124.3M | $80.0M |
| Property, Plant & Equipment | $1.1M | $1.0M | $1.1M | $998.0K |
| Goodwill | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — |
| Total Assets | $268.7M | $146.9M | $139.8M | $97.1M |
| Liabilities | ||||
| Accounts Payable | $4.9M | $6.4M | $3.8M | $2.7M |
| Total Current Liabilities | $16.8M | $22.8M | $17.2M | $14.3M |
| Long-Term Debt | — | — | — | — |
| Total Liabilities | $22.0M | $30.1M | $26.3M | $25.0M |
| Stockholders' Equity | ||||
| Retained Earnings | $-380.1M | $-280.2M | $-181.8M | $-115.4M |
| Total Stockholders' Equity | $246.7M | $116.8M | $113.5M | $-113.0M |